版本:
中国

BRIEF-Alnylam Pharmaceuticals reports Q1 loss per share of $1.25 including items

May 5 Alnylam Pharmaceuticals Inc

* Alnylam pharmaceuticals reports first quarter 2017 financial results and highlights recent period activity

* Q1 revenue $19 million versus I/B/E/S view $23.6 million

* Q1 loss per share $1.25 including items Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐